Topiramate News
Most Popular Topiramate Story
Spotlight shifts to Vivus' Qnexa
Few developers have enjoyed the kind of attention that's been lavished on the three biotech companies seeking approval for their new obesity drugs. The focus will hit fever pitch Thursday when an FDA Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
